Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CONSUN PHARMA to Invest Approx. RMB191M to Acquire 30% Stake in Shanghai Huamao Pharmaceutical
Recommend 0 Positive 1 Negative 0 |
||||
|
||||
|
CONSUN PHARMA (01681.HK) announced that on 8 June 2026, Guangzhou Consun, a wholly-owned subsidiary of the Company, entered into an investment agreement with Shanghai Huamao Pharmaceutical, and its existing shareholders. Guangzhou Consun will make an aggregate investment of RMB191 million through the acquisition of existing equity interests and capital increase in cash. Upon completion of the transaction, Guangzhou Consun shall hold 30% equity interest in the Target Company. The Target Company shall become an associate of the Company and the financial results of which will not be consolidated into the financial statements of the Group. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
